Adjia Hamadjida

7PUBLICATIONS
10CO-AUTHORS
Toxicology (incl. clinical toxicology)Gene and molecular therapyMolecular medicinePharmacogenomicsSimulation, modelling, and programming of mechatronics systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2025
The anti-dyskinetic effect of the clinic-ready mGluR2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat.

Judy Shaqfah, Woojin Kang, Fleur Gaudette

|Jun 27, 2024
Effect of the mGlu2 positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmoset.

Woojin Kang, Imane Frouni, Cynthia Kwan

|Jul 29, 2023
The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.

Cynthia Kwan, Imane Frouni, Dominique Bédard

|Jan 12, 2023
Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat.

Imane Frouni, Dominique Bédard, Élodie Bourgeois-Cayer

|Jan 17, 2020
The highly selective mGlu2 receptor positive allosteric modulator LY-487,379 alleviates l-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease.

Adjia Hamadjida, Lamia Sid-Otmane, Cynthia Kwan

|Oct 10, 2018
Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat.

Imane Frouni, Cynthia Kwan, Dominique Bédard

Pageof 2

Frequent Collaborators

4 joint publications

Philippe Huot

2 joint publications

Imane Frouni

2 joint publications

Fleur Gaudette

2 joint publications

Francis Beaudry